Latest filing published 19 Feb 2021 for Edesa Biotech, Inc., €29k.
Filing timeline
BuySaleInsider track record
Frank R. Oakes: trading record in brief
Frank R. Oakes appears in our data through filings on Edesa Biotech, Inc. shares, published by SEC (Form 4). Between 6 October 2020 and 18 February 2021, the trades on record add up to 3 filings.
Every open-market trade on record is a sale: 2 sales worth €38k. Besides market trades, the filings include 1 option exercise. In 2021 alone, the filings show no purchases and 2 sales.
The newest entry dates from 19 February 2021: an open-market sale of €29k, in Edesa Biotech, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Frank R. Oakes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,165 shares@ CA$7.2577.1% of flowCommon SharesTSXSEDI:3682641
- 1,827 shares@ CA$7.2522.9% of flowCommon SharesTSXSEDI:3682645
- 609 shares@ CA$4.00Common SharesTSXSEDI:3622061
3 of 3 declarations
